TriangleCisplatin (NCT06745882)
Cisplatin trial for Non-small Cell Lung Cancer (NCT06745882). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for Black adults with advanced non-small-cell lung cancer, no known EGFR, ALK or ROS1 alteration, and no prior treatment for advanced disease.
The idea: one group observes standard pembrolizumab treatment. Another uses tumor DNA in blood and PD-L1 results to select pembrolizumab alone or with chemotherapy. Pembrolizumab blocks an immune brake. Researchers compare cancer control under these treatment choices.
This phase 2 study plans 318 patients. Moffitt’s Jhanelle Gray leads it; 11 US sites are recruiting, including Tampa.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.